J IL Medical Consultants is categorized under Business Consultants in Chicago, IL and active since 2010.
J IL Medical Consultants was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Tade Akere, Administrator at the company’s single location by writing to 5500 South Damen Avenue, Chicago, Illinois IL 60636 or by phoning (773) 436-0161. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | J IL Medical Consultants |
| Contact Person: | Tade Akere, Administrator |
| Address: | 5500 South Damen Avenue, Chicago, Illinois 60636 |
| Phone Number: | (773) 436-0161 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 6211110 |
| Share This Business: |
J IL Medical Consultants was started in 2010 to provide professional Business Consultants under the SIC code 8748 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Tade Akere, Administrator for inquiries that concern J IL Medical Consultants by calling the company number (773) 436-0161, as your correspondence is most welcome. Additionally, the physical location of the single location of J IL Medical Consultants can be found at the coordinates 41.79329,-87.67433 as well as the street address 5500 South Damen Avenue in Chicago, Illinois 60636.
For its online presence, you may visit J IL Medical Consultants’s website at and engage with its social media outlets through on Twitter and on Facebook.